Insider Transactions Reported by 19 Insiders of Verona Pharma plc

Symbol
VRNA on Nasdaq
Location
3 More London Riverside, London, United Kingdom

Insiders trading volume in the past year

Verona Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Access Industries Holdings LLC 10%+ Owner $1.12B Aug 15, 2022
Rishi Gupta Director $75.6M May 11, 2023
Orbimed Advisors Llc Director $75.6M May 11, 2023
Claire Poll General Counsel $56M Feb 1, 2024
James Aloysius Brady Director $0 -$10.8K -100% Oct 7, 2025
Lisa Deschamps Director $0 -$124K -100% Oct 7, 2025
Anders Ullman Director $0 Oct 7, 2025
Kathleen A. Rickard Chief Medical Officer $0 -$3.19M -100% Oct 7, 2025
Mahendra Shah Director $0 -$47.4K -100% Oct 7, 2025
Kenneth Cunningham Director $0 -$142K -100% Oct 7, 2025
David Zaccardelli President and CEO, Director $0 -$17.2M -100% Oct 7, 2025
Martin Edwards Director $0 -$142K -100% Oct 7, 2025
Mark W. Hahn Chief Financial Officer $0 -$17.2M -100% Oct 7, 2025
Christina Ackermann Director $0 -$361K -100% Oct 7, 2025
Andrew Fisher General Counsel $0 -$1.28M -100% Oct 7, 2025
Vikas Sinha Director $0 -$2.99M -100% Oct 7, 2025
Michael Austwick Director $0 -$148K -100% Oct 7, 2025
David R. Ebsworth Director $0 -$25K -100% Oct 7, 2025
Andrew Sinclair Director Aug 9, 2021

Recent Insider Transactions by Companies or Individuals for Verona Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.